![](/img/cover-not-exists.png)
51OFirst-line pembrolizumab monotherapy in metastatic PD-L1 positive non-small cell lung cancer: A real-world analysis of time on treatment in US community oncology practices
Velcheti, V, Chandwani, S, Chen, X, Pietanza, M C, Burke, TVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy486.002
Date:
December, 2018
File:
PDF, 80 KB
english, 2018